Summary
The species dependent variation in the cardiotonic activity of selective cyclic nucleotide phosphodiesterase (PDE) isoenzyme inhibitors was examined by comparing the inotropic and PDE inhibitory effects of Org 30029 (N-hydroxy-5,6-dimethoxy-benzo[b]thiophene-2-carboximidamide HCI), 3-isobutyl-l-methylxanthine (IBMX), milrinone and rolipram in rat and rabbit ventricular myocardium. The relative activities of PDE isoenzymes in rat and rabbit cardiac ventricle were also examined to assess the role of the different PDE subtypes in modulating contractile force in the two species.
In rabbit papillary muscles, IBMX, Org 30029 and milrinone increased contractile force whilst rolipram was inactive. The rank order of potency of the active compounds was Org 30029 > IBMX > milrinone. Only Org 30029 and IBMX produced significant positive inotropic responses in rat papillary muscles, milrinone and rolipram being inactive. However, large positive inotropic responses were obtained in rat papillary muscles when milrinone and rolipram were tested in combination. In rabbit papillary muscles, the positive inotropic action of milrinone was markedly potentiated by rolipram. Four main types of PDE (I, II, III, IV) isoenzymes were resolved, by DEAE-sepharose or Mono-Q ion-exchange chromatography, from both rat and rabbit cardiac ventricular tissue. In rabbit, Ca2+/calmodulin dependent PDE (PDE I) and cyclic GMP inhibited PDE (PDE III) were the dominant cAMP activities. In contrast, cyclic GMP stimulated PDE (PDE II), PDE III and cGMP insensitive PDE (PDE IV) represented the main cAMP activities in rat cardiac ventricle. The inhibitory effects of Org 30029, IBMX, milrinone and rolipram on PDE isoenzymes from rat and rabbit cardiac ventricle were essentially similar. Milrinone and rolipram produced selective inhibition of PDE III and PDE IV, respectively. Org 30029 selectively inhibited PDE III and PDE IV whilst IBMX was non-selective and inhibited all PDE isoenzymes.
In conclusion, the results show that species-dependent differences in the inotropic action of PDE isoenzyme selective inhibitors may be related to differences in the relative cAMP activity levels of PDE isoenzymes. It seems that in order to induce positive inotropism it is necessary to inhibit a sufficient proportion of low Km cAMP PDEs (such as dual inhibition of PDE III and PDE IV) in a relevant intracellular locale.
Similar content being viewed by others
References
Ahluwalia G, Rhoads AR, Lulla M (1984) Particulate cyclic 3′,5′-nucleotide phosphodiesterase and calmodulin of cardiac muscle. Int J Biochem 16:483–488
Artman M, Kithas PA, Wike JS, Crump DB, Strada SJ (1989) Inotropic responses to cyclic nucleotide phosphodiesterase inhibitors in immature and adult rabbit myocardium. J Cardiovasc Pharmacol 13:146–154
Beavo JA (1988) Multiple isoenzymes of cyclic nucleotide phosphodiesterase. In: Greengard P, Robison GA (eds) Advances in Second Messenger and Phosphoprotein Research, Raven, New York, vol 22, pp 1–38
Beavo JA, Hardman JG, Sutherland EW (1970) Hydrolysis of cyclic guanosine and adenosine 3′,5′-monophosphates by rat and bovine tissues. J Biol Chem 245:5649–5655
Brunkhorst D, v d Leyen H, Meyer W, Nigbur R, Schmidt-Schumacher C, Scholz H (1989) Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart. Naunyn-Schmiedeberg's Arch Pharmacol 339:575–583
Challiss RAJ, Patel N, Shahid M, Nicholson CD (1990) Positive inotropism and cAMP elevation by cyclic nucleotide phosphodiesterase inhibitors in rat heart. J Mol Cell Cardiol 22 (Suppl III):S104
Dickson M, Marshall RJ, Shahid M (1987) Comparison of the positive inotropic and phosphodiesterase inhibitory effects of IBMX and milrinone in the rabbit myocardium. Br J Pharmacol 92 (Suppl 1):545P
Endoh M, Yanagisawa T, Taira N, Blinks JR (1986) Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation 73 (Suppl III):III-117–131
Frangakis CJ, Lanni C, Lasher KP, Bentley RG, Farah AE (1989) The role of cyclic AMP and the dihydropyridine sensitive channels on the mechanism of action of milrinone (Corotrope). J Cardiovasc Pharmacol 13:915–924
Gristwood RW, Owen DAA (1986) Effects of rolipram on guineapig ventricles in vitro: evidence of an unexpected synergism with SK&F 94120. Br J Pharmacol (Suppl) 87:91P
Gristwood RW, Eden RJ, Owen DAA, Taylor EW (1986) Pharmacological studies with SK&F 94120, a novel positive isotropic agent with vasodilator activity. J Pharm Pharmacol 38:452–459
Gristwood RW, English TAH, Wallwork J, Sampford KA, Owen DAA (1987) Analysis of responses to a selective phosphodiesterase III inhibitor SK&F 94120 on isolated myocardium including human ventricular myocardium from ‘end stage’ failure patients. J Cardiovasc Pharmacol 9:719–727
Katano Y, Endoh M (1990) Differential effects of RO 20–1724 and isobutylmethylxanthine on the basal force of contraction and β-adrenoceptor-mediated response in the rat ventricular myocardium. Biochem Biophys Res Comm 167:123–129
Kithas PA, Artman MA, Thompson WJ, Strada SJ (1988) Subcellular distribution of high-affinity type IV cyclic AMP phosphodiesterase activity in rabbit ventricular myocardium: relations to the effects of cardiotonic drugs. Circ Res 62:782–789
Kithas PA, Artman MA, Thompson WJ, Strada SJ (1989) Subcellular distribution of high affinity type IV cyclic AMP phosphodiesterase activities in rabbit ventricular myocardium: relations to post-natal maturation. J Mol Cell Cardiol 21:507–517
Komas N, Lugnier C, Le Bee A, Gal CS, Barthelemy G, Stoclet JC (1989) Differential sensitivity to cardiotonic drugs of cyclic AMP phosphodiesterases isolated from canine ventricular and sino-atrial enriched tissues. J Cardiovasc Pharmacol 14:213–220
Methven P, Lemon M, Bhoola K (1980) The metabolism of cyclic nucleotides in the guinea-pig pancreas. Biochem J 186:491–498
Miller DJ, Steele DS (1990) The ‘calcium sensitising’ effects of Org 30029 in saponin- or triton-skinned rat cardiac muscle. Br J Pharmacol 100:843–849
Nicholson CD, Jackman SA, Wilke R (1989) The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site. Br J Pharmacol 97:889–897
Reeves ML, Leigh BK, England PJ (1987) The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Biochem 1241:535–541
Shahid M, Rodger IW (1989) Chronotropic and isotropic actions of amrinone, carbazeran and isobutylmethylxanthine: role of phosphodiesterase inhibition. Br J Pharmacol 98:291–301
Shahid M, Cottney JE, Nicholson CD, Marshall RJ, Bruin JC, McIndewar I, Walker GB, Dickson M, Wylie K (1989a) Org 30029 a new cardiotonic agent with positive isotropic and vascular relaxant properties. Br J Pharmacol (Suppl) 96:111P
Shahid M, Cottney J, Nicholson CD, Marshall RJ, Bruin JC, McIndewar I, Walker GB, Dickson M, Wylie K, Fisher D (1989b) The biochemical effects of Org 30029 in cardiac and vascular tissues. Br J Pharmacol (Suppl) 96:186P
Shahid M, Wilson M, Nicholson CD, Marshall RJ (1990) Species-dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardium. J Pharm Pharmacol 42:283–284
Silver PJ (1989) Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterases. Am J Cardiol 63:2A–8A
Silver PJ, Harris AL, Canniff PC, Lepore RE, Bentley RG, Hamel LT, Evans DB (1989) Phosphodiesterase isozyme inhibition, activation of the cAMP system and positive inotropy mediated by milrinone in isolated guinea-pig cardiac muscle. J Cardiovasc Pharmacol 13:530–540
Taniguchí T, Fujiwara M, Lee JJ, Hidaka H (1978) Cyclic 3′,5′-nucleotide phosphodiesterase of rabbit sino-atrial node. Biochem Biophys Acta 522:465–476
Tenor H, Bartel S, Krause EG (1987) Cyclic nucleotide phosphodiesterase activity in the rat myocardium: evidence of four different PDE subtypes. Biomed Biochem Acta 46 (10):S749-S753
Weishaar RE, Kobylarz-Singer DC, Steffen RP, Kaplan HR (1987) Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility. Circ Res 61:539–547
Author information
Authors and Affiliations
Additional information
Send offprint requests to M. Shahid at the above address
Rights and permissions
About this article
Cite this article
Shahid, M., Nicholson, C.D. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram. Naunyn-Schmiedeberg's Arch Pharmacol 342, 698–705 (1990). https://doi.org/10.1007/BF00175715
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00175715